home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  June 20, 2021
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [7] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 496 active entries


Bellavista 423
Morgins, 1875

Phone: +41764927814
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


RidePharm is an experienced Swiss consulting company, offering since 2005 Business Development and in- and out-licensing activities all over Europe. 

Performing in-depth analyses of all aspects of the biotech and pharma business, enables us to promote the most promising and innovating products, technologies and markets. In close collaborations with our network comprising over 1000 biotech and pharma companies, all aspects of licensing, marketing and sales operations are put in place and followed up in order to guarantee success.  

RidePharm is consulting medium-sized Biotech and Pharma companies and offers significant advantages over conventional consulting companies in terms of speed and efficacy.

We offer:

  • Out/In licensing research for original and biosimilars products or technologies within RidePharm’s panel of companies.
  • Full assistance in licensing, technology transfer, marketing within Europe including market research and analysis, partner research, registration assistance, operational marketing and sales follow up.

We are interested in:

Our partner, specialized in mAb biosimilar development, offers 2nd and 3rd generation mAbs to Phase I.



Selected Categories:
Product Company   Service Company
- General
- in vitro
- General
- Miscellaneous
- Strategic
- Services
- Communications

Last update of this entry: May 16, 2018

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.